Xolair Omalizumab for Injection Instructions for Use

Xolair omalizumab for injection instructions for use: indications, subcutaneous dosage, warnings, and administration for moderate-to-severe allergic asthma.


Xolair Omalizumab for Injection Instructions for Use - cover page
Brand
Xolair
Category
Drugs
Document type
User Manual
Language
Chinese
Pages
17
File format
PDF
File size
862 KB
Published
17 November, 2026
Updated
17 November, 2026
MD5 checksum
9856AE069371E9A188D2C8A4BDC62018

About this manual

This Chinese package insert provides instructions for Xolair (omalizumab for injection), a 150 mg/vial lyophilized powder supplied with sterile water for injection and intended for subcutaneous use under physician supervision.

It warns of rare allergic reactions after injection, covers moderate-to-severe persistent allergic asthma in adults and adolescents aged 12 and older, and provides IgE- and weight-based dosing tables, preparation steps, injection sites, and adverse reaction information. This manual is written in Chinese.

What's inside

  • Drug Name
  • Ingredients
  • Properties
  • Indications
  • Specifications
  • Dosage and Administration
  • Adverse Reactions
  • Preparation and Handling Instructions
  • Special Populations
  • Safety Characteristics of Special Concern

Specifications

Specification150 mg/vial
Reconstituted concentration125 mg/mL
Molecular weight150,000 daltons

Frequently asked questions

What is Xolair used for?

It is used for moderate-to-severe persistent allergic asthma.

How is Xolair given?

It is given by subcutaneous injection only, in the upper arm or thigh.

Who should administer Xolair?

It should be administered by healthcare professionals.

Can it be used if particles are visible?

No, it must not be used if solid particles are present.

Download PDF (862 KB)